569 reports of this reaction
1.9% of all RUCAPARIB reports
#10 most reported adverse reaction
CARBOHYDRATE ANTIGEN 125 INCREASED is the #10 most commonly reported adverse reaction for RUCAPARIB, manufactured by pharmaand GmbH. There are 569 FDA adverse event reports linking RUCAPARIB to CARBOHYDRATE ANTIGEN 125 INCREASED. This represents approximately 1.9% of all 29,211 adverse event reports for this drug.
Patients taking RUCAPARIB who experience carbohydrate antigen 125 increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CARBOHYDRATE ANTIGEN 125 INCREASED is a less commonly reported adverse event for RUCAPARIB, but still significant enough to appear in the safety profile.
In addition to carbohydrate antigen 125 increased, the following adverse reactions have been reported for RUCAPARIB:
CARBOHYDRATE ANTIGEN 125 INCREASED has been reported as an adverse event in 569 FDA reports for RUCAPARIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
CARBOHYDRATE ANTIGEN 125 INCREASED accounts for approximately 1.9% of all adverse event reports for RUCAPARIB, making it a notable side effect.
If you experience carbohydrate antigen 125 increased while taking RUCAPARIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.